Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
My Portfolio
Replimune Group Inc
(NQ:
REPL
)
15.21
+0.41 (+2.77%)
Official Closing Price
/ Updated:
5:31 PM EST, Dec 12, 2019
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
131,800
Open
14.86
Bid (Size)
14.54 (20)
Ask (Size)
15.50 (1)
Prev. Close
14.80
Today's Range
14.54 - 15.47
52wk Range
8.880 - 18.25
Shares Outstanding
N/A
Dividend Yield
N/A
Performance
YTD
+44.86%
+44.86%
1 Month
-8.92%
-8.92%
3 Month
+25.29%
+25.29%
6 Month
+17.00%
+17.00%
1 Year
+4.36%
+4.36%
Top News
More News
Replimune Strengthens Executive Team with the Appointment of Jean Franchi as Chief Financial Officer
December 09, 2019
from
GlobeNewswire News Releases
Replimune to Present at the Piper Jaffray 31st Annual Healthcare Conference
November 26, 2019
from
GlobeNewswire News Releases
More News
Read More
NetworkNewsBreaks – Replimune Group, Inc. (NASDAQ: REPL) Secures $80 Million in Underwritten Public Offering
November 22, 2019
from
NetworkNewsWire
Replimune Announces Pricing of Public Offering
November 14, 2019
from
GlobeNewswire News Releases
NetworkNewsBreaks – Replimune Group, Inc. (NASDAQ: REPL) Secures $80 Million in Underwritten Public Offering
November 22, 2019
from
InvestorBrandNetwork
Replimune Announces Proposed Public Offering
November 12, 2019
from
GlobeNewswire News Releases
Replimune Reports Second Fiscal Quarter Financial Results and Provides Corporate Update
November 11, 2019
from
GlobeNewswire News Releases
Replimune Presents Initial Clinical Data with RP1 that Strongly Supports Expansion of Clinical Programs in Melanoma and Cutaneous Squamous Cell Carcinoma (CSCC)
November 08, 2019
from
GlobeNewswire News Releases
Replimune to Host Investor Event at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
October 31, 2019
from
GlobeNewswire News Releases
How The Pieces Add Up: IBB Headed For $139
November 22, 2019
category
ETFs
from
ETF Channel
Thursday 11/21 Insider Buying Report: ET, REPL
November 21, 2019
category
Stocks
from
Market News Video
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.